Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
Development of specific and selective boron carriers is indispensable for boron neutron capture therapy (BNCT) application. Pentagamaboronon-0 (PGB-0) is a promising candidate as boron carrier compound due to the low but selective cytotoxicity in breast cancer cells. Formerly we reported synthesis o...
Saved in:
Main Authors: | Ratna Asmah Susidarti (Author), Rohmad Yudi Utomo (Author), Lailatul Qodria (Author), Ratna Dwi Ramadani (Author), Youichiro Ohta (Author), Yoshihide Hattori (Author), Mitsunori Kirihata (Author), Edy Meiyanto (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer
by: Rohmad Yudi Utomo, et al.
Published: (2022) -
Amino Acid-Based Boron Carriers in Boron Neutron Capture Therapy (BNCT)
by: Juulia Järvinen, et al.
Published: (2023) -
Transcriptomics analyses reveal the effects of Pentagamaboronon-0-ol on PI3K/Akt and cell cycle of HER2+ breast cancer cells
by: Adam Hermawan, et al.
Published: (2023) -
Prevention and early management of carotid blowout syndrome for patients receiving head and neck salvage boron neutron capture therapy (BNCT)
by: Tien-Li Lan, et al.
Published: (2021) -
SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS
by: Rohmad Yudi Utomo, et al.
Published: (2017)